Thrivent Financial for Lutherans’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.09M Buy
19,720
+5,440
+38% +$577K ﹤0.01% 1330
2025
Q1
$1.77M Sell
14,280
-56
-0.4% -$6.95K ﹤0.01% 1362
2024
Q4
$1.77M Sell
14,336
-283
-2% -$34.8K ﹤0.01% 1523
2024
Q3
$1.63M Sell
14,619
-11,574
-44% -$1.29M ﹤0.01% 1594
2024
Q2
$2.8M Sell
26,193
-15,429
-37% -$1.65M 0.01% 1171
2024
Q1
$5.01M Sell
41,622
-322
-0.8% -$38.8K 0.01% 893
2023
Q4
$5.16M Sell
41,944
-1,782
-4% -$219K 0.01% 840
2023
Q3
$5.66M Sell
43,726
-3,661
-8% -$474K 0.01% 767
2023
Q2
$5.88M Sell
47,387
-515
-1% -$63.8K 0.01% 797
2023
Q1
$7.01M Sell
47,902
-712
-1% -$104K 0.02% 699
2022
Q4
$7.75M Sell
48,614
-36,676
-43% -$5.84M 0.02% 672
2022
Q3
$11.4M Buy
85,290
+68,513
+408% +$9.13M 0.03% 554
2022
Q2
$2.62M Buy
16,777
+287
+2% +$44.8K 0.01% 1085
2022
Q1
$2.57M Buy
16,490
+206
+1% +$32.1K 0.01% 1180
2021
Q4
$2.08M Buy
16,284
+237
+1% +$30.2K ﹤0.01% 1367
2021
Q3
$2.09M Buy
16,047
+43
+0.3% +$5.6K ﹤0.01% 1322
2021
Q2
$2.84M Buy
16,004
+992
+7% +$176K 0.01% 1198
2021
Q1
$2.47M Sell
15,012
-792,382
-98% -$130M 0.01% 1283
2020
Q4
$133M Sell
807,394
-1,331
-0.2% -$220K 0.31% 61
2020
Q3
$115M Buy
808,725
+306,546
+61% +$43.7M 0.31% 68
2020
Q2
$55.4M Buy
502,179
+936
+0.2% +$103K 0.17% 149
2020
Q1
$50M Sell
501,243
-74,826
-13% -$7.46M 0.18% 141
2019
Q4
$86M Buy
576,069
+28,106
+5% +$4.2M 0.24% 100
2019
Q3
$70.2M Sell
547,963
-12,337
-2% -$1.58M 0.22% 122
2019
Q2
$79.9M Buy
560,300
+13,500
+2% +$1.92M 0.24% 99
2019
Q1
$78.2M Buy
546,800
+431,150
+373% +$61.6M 0.25% 97
2018
Q4
$14.3M Buy
115,650
+10,990
+11% +$1.36M 0.05% 367
2018
Q3
$17.6M Buy
104,660
+1,680
+2% +$282K 0.06% 358
2018
Q2
$17.7M Buy
102,980
+83,640
+432% +$14.4M 0.06% 349
2018
Q1
$2.92M Buy
+19,340
New +$2.92M 0.01% 780
2014
Q2
Sell
-36,600
Closed -$5.08M 1725
2014
Q1
$5.08M Buy
+36,600
New +$5.08M 0.03% 441